Structure

InChI Key MAKUBRYLFHZREJ-JWBQXVCJSA-M
Smile CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(=O)[O-])O[C@@H](O)[C@H](O)[C@H]1O.[Na+]
InChI
InChI=1S/C14H23NO11.Na/c1-4(17)15-5-2-6(18)7(3-16)24-14(5)26-10-8(19)9(20)13(23)25-11(10)12(21)22;/h5-11,13-14,16,18-20,23H,2-3H2,1H3,(H,15,17)(H,21,22);/q;+1/p-1/t5-,6+,7-,8-,9-,10+,11+,13-,14+;/m1./s1

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Dry Eye Syndromes 3 D015352 ClinicalTrials
Osteoarthritis 3 D010003 ClinicalTrials
Osteoarthritis, Hip 3 D015207 ClinicalTrials
Osteoarthritis, Knee 3 D020370 ClinicalTrials
Shoulder Impingement Syndrome 2 D019534 ClinicalTrials
Pulmonary Disease, Chronic Obstructive 2 D029424 ClinicalTrials
Carpal Tunnel Syndrome 1 D002349 ClinicalTrials
Intervertebral Disc Degeneration 1 D055959 ClinicalTrials

Related Entries

Scaffolds

Cross References

Resources Reference
ChEMBL CHEMBL4594244
FDA SRS YSE9PPT4TH